VTRS
Viatris Inc.
Company Overview
| Mkt Cap | $11.54B | Price | $10.36 |
| Volume | 12.30M | Change | +0.00% |
| P/E Ratio | -18.2 | Open | $10.31 |
| Revenue | $14.7B | Prev Close | $10.36 |
| Net Income | $-634.2M | 52W Range | $6.85 - $13.55 |
| Div Yield | 0.48% | Target | $12.03 |
| Overall | 80 | Value | 80 |
| Quality | -- | Technical | 81 |
No chart data available
Stock Overview
Updated DailyViatris Inc. (VTRS) is a leading Healthcare company in the Drug Manufacturers-Specialty & Generic industry, currently trading at $10.36 with a market capitalization of $11.54 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows VTRS with a volume of 12.30 million shares. The stock opened down 0.48% from yesterday's close of $10.36. Current analyst estimates project earnings of $2.31 per share for this year, with next year targeting $2.43.
VTRS demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for VTRS include excellent overall investment profile. The company offers a dividend yield of 0.48% and analyst price targets suggest potential upside of 16.1%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 12:24 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTRS | $10.36 | 0% | 12.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |